| Literature DB >> 29486760 |
Yinghong Ji1, Xianfang Rong1, Yi Lu2.
Abstract
BACKGROUND: While pars plana vitrectomy (PPV) has become the third most commonly performed surgery in the world, it can also induce multiple post complications easily. Among them, cataract progression is the most frequent one that can lead to blindness eventually.Entities:
Keywords: Aqueous humor (AH); Metabolite-metabolite correlation; Metabolomics; Pars plana vitrectomy (PPV)
Mesh:
Substances:
Year: 2018 PMID: 29486760 PMCID: PMC5830316 DOI: 10.1186/s12886-018-0729-y
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Summary of human aqueous humor samples
| Group | Patient ID | Gender | Age range (Years old) | Axial length | LOCSIII |
|---|---|---|---|---|---|
| Controls | A36_1 | Female | 50–55 | 24.32 | C3N3P3 |
| A37_1 | Female | 50–55 | 24.75 | C2N2P5 | |
| A38_1 | Female | 50–55 | 24.63 | C3N4P2 | |
| A39_1 | Female | 55–60 | 22.59 | C3N3P2 | |
| A40_1 | Male | 60–65 | 24.65 | C2N3P2 | |
| A41_1 | Male | 60–65 | 23.2 | C3N2P4 | |
| A42_1 | Male | 65–70 | 23.8 | C3N3P3 | |
| A43_1 | Male | 65–70 | 24.01 | C4N5 | |
| A44_1 | Female | 65–70 | 22.96 | C4N5 | |
| A45_1 | Male | 70–75 | 23.63 | C5N4P2 | |
| Patients after pars plana vitrectomy | P1_1 | Male | 50–55 | 26.92 | C2N5P3 |
| P2_1 | Male | 50–55 | 25.76 | C2N4P2 | |
| P3_1 | Male | 50–55 | 29.63 | C3N5P4 | |
| P4_1 | Female | 55–60 | 27.79 | C2N3P3 | |
| P5_1 | Female | 55–60 | 25.63 | C3N3P2 | |
| P6_1 | Female | 60–65 | 26.53 | C3N4P3 | |
| P7_1 | Female | 60–65 | 23.94 | C3N4P3 | |
| P8_1 | Female | 60–65 | 24.91 | C2N3P2 | |
| P9_1 | Male | 60–65 | 25.45 | C2N3P2 | |
| P10_1 | Male | 70–75 | 25.78 | C3N4P3 |
Fig. 1Metabolic variation between the controls and patients after PPV. a Heat map representation of 263 metabolites detected in 20 AH samples, showing 6 classes by clustering analysis. Each line represents one metabolite. The deeper the green color, the lowest its content in the AH sample; similarly, the deeper the red color, the highest its content in the AH sample. b PLS-DA score plot for the first two components (t[2] / t[1]) model for the controls and patients after PPV. c PLS-DA S loading plot for the two first components (w*c[2] / w*c[1]) for the controls and patients after PPV. Metabolites responsible for separation are labeled with red triangle
List of different metabolites between patients after PPV and the controls, responsible for the separation
| Super Pathway | Biochemical Name | Retention time (minutes) | Ratio(PPV/ARC)* | |
|---|---|---|---|---|
| Amino acid | 4-Acetamidobutyric acid 1 | 9.96 | 0.34 | 0.0347 |
| Lipids | Glutaric Acid | 9.31 | 0.43 | 0.0371 |
| Pelargonic acid | 9.05 | 0.67 | 0.0173 | |
| Others | 3-(2-Hydroxyphenyl)propionic acid | 11.16 | 2.04 | 0.0019 |
| Analyte 389 | 14.16 | 0.59 | 0.0457 | |
| unknown 029 | 9.64 | 1.55 | 0.0183 | |
| unknown 037 | 10.39 | 0.70 | 0.0198 | |
| unknown 056 | 13.85 | 0.60 | 0.0142 |
*ARC represented the controls
Fig. 2Metabolite-metabolite correlation analysis in the controls (The control group). Metabolites were shown in X and Y-axes, grouped by pathway information. Both p and r values of the correlations between every two metabolites were displayed in distinct colors
Fig. 3Metabolite-metabolite correlation analysis in patients after PPV (The experiment group). Metabolites were shown in X and Y-axes, grouped by pathway information. Both p and r values of the correlations between every two metabolites were displayed in distinct colors